Elevance Health, Inc.

ELVNYSEUSD
392.55 USD
3.52 (0.91%)🟢LIVE (AS OF 11:17 AM EDT)
🟢Market: OPEN
Open?$392.26
High?$396.44
Low?$384.60
Prev. Close?$389.03
Volume?266.8K
Avg. Volume?1.8M
VWAP?$394.11
Rel. Volume?0.15x
Bid / Ask
Bid?$390.69 × 120
Ask?$391.30 × 40
Spread?$0.61
Midpoint?$391.00
Valuation & Ratios
Market Cap?84.5B
Shares Out?217.2M
Float?220.5M
Float %?99.9%
P/E Ratio?16.11
P/B Ratio?1.92
EPS?$24.14
Dividend?1.80%
Ex-Dividend?2026-06-10

ELV is currently priced at $392.55. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 2, 2026.

RelatedCNCUNHMOH
News
Profile
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Employees
97.1K
Market Cap
87.4B
Industry
HOSPITAL & MEDICAL SERVICE PLANS
Listed
2001-10-30
Address
220 VIRGINIA AVENUE
INDIANAPOLIS, IN 46204
Phone: (800) 331-1476
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
50
Momentum?
8
Short Sent.?
68
Piotroski F-Score?4/9Mixed
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?2.77%Low
Short Interest?6.1M
Days to Cover?3.7
Free Float220.5M
Avg Daily Volume1.7M
Settlement Date2026-05-15
Financial Health
Current Ratio?4.07Strong
Quick Ratio?4.07Strong
Cash Ratio?1.21Strong
Debt/Equity?0.73Moderate
ValuationATTRACTIVELY VALUEDvs 3 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
77
16.1CHEAP
P/B?
Peers
75
S&P
76
1.92CHEAP
P/S?
Peers
50
S&P
97
0.42CHEAP
P/FCF?
Peers
75
S&P
80
13.1CHEAP
EV/EBITDA?
Peers
75
S&P
70
11.7CHEAP
EV/Sales?
Peers
50
S&P
97
0.53CHEAP
Returns & Efficiency
ROE?
Peers
67
S&P
43
11.9%FAIR
ROA?
Peers
100
S&P
38
4.2%FAIR
Cash Flow & Enterprise
FCF?$6.5B
Enterprise Value?$106.7B
Fundamentals ratios updated end of day